Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Previous issues

Page Path
HOME > Browse > Previous issues
11 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 40(3); June 2016
Prev issue Next issue
Review
Epidemiology
Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population
Bo Kyung Koo, Min Kyong Moon
Diabetes Metab J. 2016;40(3):175-181.   Published online May 24, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.175
  • 4,959 View
  • 40 Download
  • 21 Web of Science
  • 19 Crossref
AbstractAbstract PDFPubReader   

In the early 2000s, the prevalence of diabetes in adults aged ≥30 years in Korea was about 9% to 10%, and it remained stable. However, a nationwide survey showed that this prevalence increased over the past few years. After age-standardization using the Korean population of the year 2010, the prevalence of diabetes in adults aged ≥30 years was 10.0% to 10.8% between 2001 and 2012, which increased to 12.5% in 2013 and 11.6% in 2014. During that period, there have been changes in the gender- and age-specific prevalence of diabetes in Korean adults. The prevalence of diabetes in the elderly population increased significantly, while this prevalence in young adults, especially in young women, did not change significantly. The contribution of each diabetic risk factor, such as obesity, β-cell dysfunction, sarcopenia, and socioeconomic status, in developing diabetes has also changed during that period in each gender and age group. For young women, obesity was the most important risk factor; by contrast, for elderly diabetic patients, sarcopenia was more important than obesity as a risk factor. Considering the economic burden of diabetes and its associated comorbidities, a public health policy targeting the major risk factors in each population might be more effective in preventing diabetes.

Citations

Citations to this article as recorded by  
  • Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
    Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
    Advances in Therapy.2024; 41(5): 1967.     CrossRef
  • Association between physical activity level and diabetes incidence among Chinese middle-aged and older adults: a cross-sectional study from the China health and retirement longitudinal study
    Yunqing Zhang, Fanhao Meng, Xueyin Fei, Ke Wang, Yigao Wu, Xueting Wang
    Frontiers in Public Health.2024;[Epub]     CrossRef
  • Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19
    Hui Long, Jiachen Li, Rui Li, Haiyang Zhang, Honghan Ge, Hui Zeng, Xi Chen, Qingbin Lu, Wanli Jiang, Haolong Zeng, Tianle Che, Xiaolei Ye, Liqun Fang, Ying Qin, Qiang Wang, Qingming Wu, Hao Li, Wei Liu
    Epidemiology and Infection.2022;[Epub]     CrossRef
  • Type 2 Diabetes Mellitus with Early Dry Skin Disorder: A Comparison Study Between Primary and Tertiary Care in Indonesia
    Lili Legiawati, Kusmarinah Bramono, Wresti Indriatmi, Em Yunir, Aditya Indra Pratama
    Current Diabetes Reviews.2022;[Epub]     CrossRef
  • Physical Comorbidity According to Diagnoses and Sex among Psychiatric Inpatients in South Korea
    Suin Park, Go-Un Kim, Hyunlye Kim
    International Journal of Environmental Research and Public Health.2021; 18(8): 4187.     CrossRef
  • Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
    Bo Kyung Koo, Seoil Moon, Min Kyong Moon
    BMC Geriatrics.2021;[Epub]     CrossRef
  • Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
    Suk Kyeong Kim, Ju-Young Jang, Dong-Lim Kim, Young A Rhyu, Suh Eun Lee, Seung-Hyun Ko, Kyungdo Han, Kee-Ho Song
    The Korean Journal of Internal Medicine.2020; 35(3): 641.     CrossRef
  • Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus
    Soo Kyoung Kim, Jaehoon Jung, Jung Hwa Jung, NalAe Yoon, Sang Soo Kang, Gu Seob Roh, Jong Ryeal Hahm
    Complementary Therapies in Medicine.2020; 52: 102524.     CrossRef
  • Taking metformin and cognitive function change in older patients with diabetes
    Bo Kyung Koo, Lee‐Kyung Kim, Jun‐Young Lee, Min Kyong Moon
    Geriatrics & Gerontology International.2019; 19(8): 755.     CrossRef
  • Trends in Diabetes Prevalence, Awareness, Treatment and Control in Yangon Region, Myanmar, Between 2004 and 2014, Two Cross-Sectional Studies
    Wai Phyo Aung, Espen Bjertness, Aung Soe Htet, Hein Stigum, Marte Karoline Råberg Kjøllesdal
    International Journal of Environmental Research and Public Health.2019; 16(18): 3461.     CrossRef
  • Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease
    Satoshi Ida, Yuji Kojima, Shima Hamaoka, Naohito Urawa, Jun Araki, Ryutaro Kaneko, Kazuya Murata
    Journal of Gastroenterology and Hepatology.2019; 34(5): 947.     CrossRef
  • Letter: Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90–6)
    Bo Kyung Koo
    Diabetes & Metabolism Journal.2019; 43(2): 242.     CrossRef
  • Antidiabetic Effects of Vigna nakashimae Extract in Humans: A Preliminary Study
    Soo Kyoung Kim, Jaehoon Jung, Jung Hwa Jung, Byong Won Lee, Sang Soo Kang, Gu Seob Roh, Jong Ryeal Hahm
    The Journal of Alternative and Complementary Medicine.2018; 24(3): 249.     CrossRef
  • Serum Betatrophin Concentrations and the Risk of Incident Diabetes: A Nested Case-Control Study from Chungju Metabolic Disease Cohort
    Seung-Hwan Lee, Marie Rhee, Hyuk-Sang Kwon, Yong-Moon Park, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2018; 42(1): 53.     CrossRef
  • Relationship between age and cardiometabolic index in Japanese men and women
    Ichiro Wakabayashi
    Obesity Research & Clinical Practice.2018; 12(4): 372.     CrossRef
  • Kidney transplantation in patients with diabetes: better than nothing
    Chang Seong Kim
    The Korean Journal of Internal Medicine.2018; 33(2): 293.     CrossRef
  • The Changes of Macular Microvasculature and Related Systemic Parameters in Diabetic Patients without Diabetic Retinopathy
    Sang Wook Choi, Joon Hee Cho, Ha Kyung Kim, So Hyun Bae
    Journal of the Korean Ophthalmological Society.2017; 58(7): 811.     CrossRef
  • Dietary total, animal, vegetable calcium and type 2 diabetes incidence among Korean adults: The Korean Multi-Rural Communities Cohort (MRCohort)
    J.M. Oh, H.W. Woo, M.K. Kim, Y.-H. Lee, D.H. Shin, M.-H. Shin, B.Y. Choi
    Nutrition, Metabolism and Cardiovascular Diseases.2017; 27(12): 1152.     CrossRef
  • The Influence of Prenatal Exercise on Offspring Health: A Review
    Carmen Moyer, Olga Roldan Reoyo, Linda May
    Clinical Medicine Insights: Women's Health.2016; 9: CMWH.S34670.     CrossRef
Sulwon Lecture 2015
Clinical Care/Education
Sarcopenia, Frailty, and Diabetes in Older Adults
Hak Chul Jang
Diabetes Metab J. 2016;40(3):182-189.   Published online April 20, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.182
  • 7,457 View
  • 160 Download
  • 83 Web of Science
  • 80 Crossref
AbstractAbstract PDFPubReader   

Populations are aging and the prevalence of diabetes mellitus is increasing tremendously. The number of older people with diabetes is increasing unexpectedly. Aging and diabetes are both risk factors for functional disability. Thus, increasing numbers of frail or disabled older patients with diabetes will increase both direct and indirect health-related costs. Diabetes has been reported as an important risk factor of developing physical disability in older adults. Older people with diabetes have lower muscle mass and weaker muscle strength. In addition, muscle quality is poorer in diabetic patients. Sarcopenia and frailty have a common soil and may share a similar pathway for multiple pathologic processes in older people. Sarcopenia is thought to be an intermediate step in the development of frailty in patients with diabetes. Thus, early detection of sarcopenia and frailty in older adults with diabetes should be routine clinical practice to prevent frailty or to intervene earlier in frail patients.

Citations

Citations to this article as recorded by  
  • Glycemic control and prescription profiles in internal medicine inpatients: The role of frailty
    Jose Carlos Arévalo Lorido, Juana Carretero Gomez, Patricia Vazquez Rodriguez, Ricardo Gómez Huelgas, Carmen Marín Silvente, Fernando Javier Sánchez Lora, Elena Isaba Ares, Anna Pardo i Pelegrín, Onán Pérez Hernández, Javier Ena
    European Journal of Internal Medicine.2024; 121: 103.     CrossRef
  • Prolonged hospitalization and 1-year mortality are associated with sarcopenia and malnutrition in older patients with type 2 diabetes: A prospective cohort study
    Mileni Vanti Beretta, Tatiana Pedroso de Paula, Ticiana da Costa Rodrigues, Thais Steemburgo
    Diabetes Research and Clinical Practice.2024; 207: 111063.     CrossRef
  • The role of genes and myokines of developing sarcopenia: A review
    Farida V. Valeeva, Zhanna A. Rodygina, Tatyana S. Yilmaz
    Consilium Medicum.2024; 26(4): 219.     CrossRef
  • Effect of Frailty on Depression among Patients with Late-life Depression: A Test of Anger, Anxiety, and Resilience as Mediators
    Junhyung Kim, Hyun-Ghang Jeong, Moon-Soo Lee, Chi-Un Pae, Ashwin A. Patkar, Sang Won Jeon, Cheolmin Shin, Changsu Han
    Clinical Psychopharmacology and Neuroscience.2024; 22(2): 253.     CrossRef
  • Relationship Between Frailty and Diabetic Pharmacologic Therapy in Older Adults with Type 2 Diabetes: A Cross-Sectional Study
    Akiko Nishimura, Chie Masuda, Chiyo Murauchi, Miho Ishii, Yuko Murata, Terumi Kawasaki, Mayumi Azuma, Shin-ichi Harashima
    Drugs & Aging.2024; 41(6): 531.     CrossRef
  • Association between sarcopenia and frailty in middle-aged and elder population: Findings from the China health and retirement longitudinal study
    Yue Dong, Yuzhi Xi, Yahui Wang, Zhijun Chai
    Journal of Global Health.2024;[Epub]     CrossRef
  • Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis
    Jiarui Zheng, Shuo Yang, Wenhui Ren, Juan Zhong, Xin Liu, Rui Han, Tingyang Wei, Changjie Tie, Yuteng Yang, Chengwu Hong, Bo Feng, Rui Huang
    Heliyon.2024; 10(15): e35354.     CrossRef
  • Advances in Cognitive Decline in Elderly Patients with Diabetes Mellitus
    媛媛 冯
    Advances in Clinical Medicine.2024; 14(08): 1588.     CrossRef
  • Urgent needs of caregiving in ageing populations with Alzheimer’s disease and other chronic conditions: Support our loved ones
    John W. Culberson, Jonathan Kopel, Ujala Sehar, P. Hemachandra Reddy
    Ageing Research Reviews.2023; 90: 102001.     CrossRef
  • Hand grip strength: A reliable assessment tool of frailty status on the person with type 2 diabetes mellitus
    Diogo Ramalho, Leonor Silva, Catarina Almeida, Luís Rocha, Gustavo Rocha, Rafaela Veríssimo
    Nutrition Clinique et Métabolisme.2023; 37(1): 45.     CrossRef
  • Comprehensive review: Frailty in pancreas transplant candidates and recipients
    Ronald F. Parsons, Ekamol Tantisattamo, Wisit Cheungpasitporn, Arpita Basu, Yee Lu, Krista L. Lentine, Kenneth J. Woodside, Neeraj Singh, Joseph Scalea, Tarek Alhamad, Ty B. Dunn, Franco H. Cabeza Rivera, Sandesh Parajuli, Martha Pavlakis, Matthew Cooper
    Clinical Transplantation.2023;[Epub]     CrossRef
  • Development and validation of a risk prediction model for frailty in patients with diabetes
    Fan Bu, Xiao-hui Deng, Na-ni Zhan, Hongtao Cheng, Zi-lin Wang, Li Tang, Yu Zhao, Qi-yuan Lyu
    BMC Geriatrics.2023;[Epub]     CrossRef
  • Amino Acid Profiles in Older Adults with Frailty: Secondary Analysis from MetaboFrail and BIOSPHERE Studies
    Riccardo Calvani, Anna Picca, Leocadio Rodriguez-Mañas, Matteo Tosato, Hélio José Coelho-Júnior, Alessandra Biancolillo, Olga Laosa, Jacopo Gervasoni, Aniello Primiano, Lavinia Santucci, Ottavia Giampaoli, Isabelle Bourdel-Marchasson, Sophie C. Regueme, A
    Metabolites.2023; 13(4): 542.     CrossRef
  • Where to Start? Physical Assessment, Readiness, and Exercise Recommendations for People With Type 1 or Type 2 Diabetes
    Marni Armstrong, Sheri R. Colberg, Ronald J. Sigal
    Diabetes Spectrum.2023; 36(2): 105.     CrossRef
  • The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy
    Huiling Chen, Xiaojing Huang, Meiyuan Dong, Song Wen, Ligang Zhou, Xinlu Yuan
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1541.     CrossRef
  • Analysis of Individual Components of Frailty in Simultaneous Pancreas and Kidney, and Solitary Pancreas Transplant Recipients
    Sandesh Parajuli, Jon Odorico, Isabel Breyer, Emily Zona, Fahad Aziz, Heather Lorden, Jacqueline Garonzik-Wang, Dixon Kaufman, Didier Mandelbrot
    Transplantation Direct.2023; 9(9): e1523.     CrossRef
  • Effects of moderate exercise versus light exercise on fasting blood glucose in obese patients with type 2 diabetes mellitus
    Manal Kamel Youssef
    Physiotherapy Quarterly.2023; 31(3): 101.     CrossRef
  • Risk factors associated with frailty in older adults with type 2 diabetes: A cross‐sectional study
    Chia‐Ling Lin, Neng‐Chun Yu, Hsueh‐Ching Wu, Yuan‐Ching Liu
    Journal of Clinical Nursing.2022; 31(7-8): 967.     CrossRef
  • Sarcopenia in patients with multiple sclerosis
    Hatice Yuksel, Mehtap Balaban, Ozlem Ozturk Tan, Semra Mungan
    Multiple Sclerosis and Related Disorders.2022; 58: 103471.     CrossRef
  • Amino acid profile of skeletal muscle loss in type 2 diabetes: Results from a 7-year longitudinal study in asians
    Serena Low, Jiexun Wang, Angela Moh, Su Fen Ang, Keven Ang, Yi-Ming Shao, Jianhong Ching, Hai Ning Wee, Lye Siang Lee, Jean-Paul Kovalik, Wern Ee Tang, Ziliang Lim, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
    Diabetes Research and Clinical Practice.2022; 186: 109803.     CrossRef
  • Assessment of Muscle Quantity, Quality and Function
    Bo Kyung Koo
    Journal of Obesity & Metabolic Syndrome.2022; 31(1): 9.     CrossRef
  • Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity
    Ah Young Leem, Young Sam Kim, Kung Soo Chung, Moo Suk Park, Young Ae Kang, Young-Mok Park, Ji Ye Jung
    Respiratory Research.2022;[Epub]     CrossRef
  • Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus
    Serena Low, Kiat Sern Goh, Tze Pin Ng, Angela Moh, Su Fen Ang, Jonathon Khoo, Keven Ang, Philip Yap, Chin Yee Cheong, Wern Ee Tang, Ziliang Lim, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
    Journal of Diabetes and its Complications.2022; 36(9): 108258.     CrossRef
  • Frailty and diabetes in older adults: Overview of current controversies and challenges in clinical practice
    Mohd Zaquan Arif Abd.Ghafar, Mark O’Donovan, Duygu Sezgin, Elizabeth Moloney, Ángel Rodríguez-Laso, Aaron Liew, Rónán O’Caoimh
    Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
  • Implications of the Metabolic Control of Diabetes in Patients with Frailty Syndrome
    Marta Muszalik, Hubert Stępień, Grażyna Puto, Mateusz Cybulski, Donata Kurpas
    International Journal of Environmental Research and Public Health.2022; 19(16): 10327.     CrossRef
  • Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
    Ji Young Lee, Minyoung Lee, Dong-Hee Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
    Endocrinology and Metabolism.2022; 37(4): 684.     CrossRef
  • Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?
    Nicklas H. Rasmussen, Peter Vestergaard
    Best Practice & Research Clinical Rheumatology.2022; 36(3): 101779.     CrossRef
  • Predictors associated with prefrailty in older Taiwanese individuals with type 2 diabetes
    Shu-Fen Lee, Chih-Ping Li, Yen-Lin Chen, Dee Pei
    Medicine.2022; 101(38): e30432.     CrossRef
  • Association of walking speed with cognitive function in Chinese older adults: A nationally representative cohort study
    Jianping Liu, Kaiwang Cui, Qian Chen, Zhiteng Li, Jing Fu, Xiangwen Gong, Hui Xu
    Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
  • Lower insulin level is associated with sarcopenia in community-dwelling frail and non-frail older adults
    Yanxia Lu, Wee Shiong Lim, Xia Jin, Ma Schwe Zin Nyunt, Tamas Fulop, Qi Gao, Su Chi Lim, Anis Larbi, Tze Pin Ng
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults
    Nam Hoon Kim, Yousung Park, Nan Hee Kim, Sin Gon Kim
    Age and Ageing.2021; 50(3): 780.     CrossRef
  • Examining the links between regular leisure‐time physical activity, sitting time and prefrailty in community‐dwelling older adults
    Shu‐Hung Chang, Nai‐Hui Chien, Jackson Pui‐Man Wai, Ching‐Cheng Chiang, Ching‐Yi Yu
    Journal of Advanced Nursing.2021; 77(6): 2761.     CrossRef
  • Tale of the Frail: Understanding Frailty in Cirrhosis
    Faruq Pradhan, Natasha Narang, Michael Fallon
    Southern Medical Journal.2021; 114(3): 186.     CrossRef
  • Type 2 diabetes mellitus in older adults: clinical considerations and management
    Srikanth Bellary, Ioannis Kyrou, James E. Brown, Clifford J. Bailey
    Nature Reviews Endocrinology.2021; 17(9): 534.     CrossRef
  • Low Protein Intakes and Poor Diet Quality Associate with Functional Limitations in US Adults with Diabetes: A 2005–2016 NHANES Analysis
    Stephanie M. Fanelli, Owen J. Kelly, Jessica L. Krok-Schoen, Christopher A. Taylor
    Nutrients.2021; 13(8): 2582.     CrossRef
  • Yaşlı Diyabetik Hastalarda Malnutrisyonun Klinik Sonuçları ve Önemi
    Saadet KOÇ OKUDUR, Pinar SOYSAL
    OSMANGAZİ JOURNAL OF MEDICINE.2021;[Epub]     CrossRef
  • Combined Aerobic and Resistance Exercise Training Reduces Circulating Apolipoprotein J Levels and Improves Insulin Resistance in Postmenopausal Diabetic Women
    Yun Kyung Jeon, Sang Soo Kim, Jong Ho Kim, Hyun Jeong Kim, Hyun Jun Kim, Jang Jun Park, Yuen Suk Cho, So Hee Joung, Ji Ryang Kim, Bo Hyun Kim, Sang Heon Song, In Joo Kim, Yong Ki Kim, Young-Bum Kim
    Diabetes & Metabolism Journal.2020; 44(1): 103.     CrossRef
  • Effects of elastic band exercise on the frailty states in pre-frail elderly people
    Rujie Chen, Qingwen Wu, Dongyan Wang, Zhou Li, Howe Liu, Guangtian Liu, Ying Cui, Linlin Song
    Physiotherapy Theory and Practice.2020; 36(9): 1000.     CrossRef
  • Association between Lower Extremity Skeletal Muscle Mass and Impaired Cognitive Function in Type 2 Diabetes
    Serena Low, Tze Pin Ng, Chin Leong Lim, Angela Moh, Su Fen Ang, Jiexun Wang, Kiat Sern Goh, Keven Ang, Wern Ee Tang, Pek Yee Kwan, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
    Scientific Reports.2020;[Epub]     CrossRef
  • Low free triiodothyronine levels are associated with risk of frailty in older adults with type 2 diabetes mellitus
    Shuangling Xiu, Zhijing Mu, Lei Zhao, Lina Sun
    Experimental Gerontology.2020; 138: 111013.     CrossRef
  • The Biomechanics of Diabetes Mellitus and Limb Preservation
    Jonathan M. Labovitz, Dana Day
    Clinics in Podiatric Medicine and Surgery.2020; 37(1): 151.     CrossRef
  • Inorganic Arsenic Exposure Decreases Muscle Mass and Enhances Denervation-Induced Muscle Atrophy in Mice
    Chang-Mu Chen, Min-Ni Chung, Chen-Yuan Chiu, Shing-Hwa Liu, Kuo-Cheng Lan
    Molecules.2020; 25(13): 3057.     CrossRef
  • Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications
    Sandra Maria Barbalho, Uri Adrian Prync Flato, Ricardo José Tofano, Ricardo de Alvares Goulart, Elen Landgraf Guiguer, Cláudia Rucco P. Detregiachi, Daniela Vieira Buchaim, Adriano Cressoni Araújo, Rogério Leone Buchaim, Fábio Tadeu Rodrigues Reina, Piero
    International Journal of Molecular Sciences.2020; 21(10): 3607.     CrossRef
  • The relationships between sarcopenic skeletal muscle loss during ageing and macronutrient metabolism, obesity and onset of diabetes
    Ailsa A. Welch, Richard P. G. Hayhoe, Donnie Cameron
    Proceedings of the Nutrition Society.2020; 79(1): 158.     CrossRef
  • Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study
    Jee Hee Yoo, Gyuri Kim, Sung Woon Park, Min Sun Choi, Jiyeon Ahn, Sang-Man Jin, Kyu Yeon Hur, Moon-Kyu Lee, Mira Kang, Jae Hyeon Kim
    Scientific Reports.2020;[Epub]     CrossRef
  • Sarcopenia, nutritional status and type 2 diabetes mellitus: A cross‐sectional study in a group of Mexican women residing in a nursing home
    María C. Velázquez‐Alva, María E. Irigoyen‐Camacho, Marco A. Zepeda‐Zepeda, Irina Lazarevich, Isabel Arrieta‐Cruz, Carlos D'Hyver
    Nutrition & Dietetics.2020; 77(5): 515.     CrossRef
  • Assessing the association between optimal energy intake and all‐cause mortality in older patients with diabetes mellitus using the Japanese Elderly Diabetes Intervention Trial
    Takuya Omura, Yoshiaki Tamura, Takuya Yamaoka, Yukio Yoshimura, Takashi Sakurai, Hiroyuki Umegaki, Chiemi Kamada, Satoshi Iimuro, Yasuo Ohashi, Hideki Ito, Atsushi Araki
    Geriatrics & Gerontology International.2020; 20(1): 59.     CrossRef
  • Sarkopenie im Kontext von Insulinresistenz und Diabetes mellitus im Alter – Daten aus der Berliner Altersstudie II
    Dominik Spira, Nikolaus Buchmann, Knut Mai, Thomas Bobbert, Joachim Spranger, Ilja Demuth, Elisabeth Steinhagen-Thiessen
    Diabetologie und Stoffwechsel.2020; 15(05): 400.     CrossRef
  • Effect of Dietary Silk Peptide on Obesity, Hyperglycemia, and Skeletal Muscle Regeneration in High-Fat Diet-Fed Mice
    Kippeum Lee, Heegu Jin, Sungwoo Chei, Hyun-Ji Oh, Jeong-Yong Lee, Boo-Yong Lee
    Cells.2020; 9(2): 377.     CrossRef
  • Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty
    Yoshiaki Tamura, Takuya Omura, Kenji Toyoshima, Atsushi Araki
    Nutrients.2020; 12(11): 3367.     CrossRef
  • Mechanical Properties of Single Muscle Fibers: Understanding Poor Muscle Quality in Older Adults with Diabetes
    Eun-Jeong Lee, Hak Chul Jang, Kyung-Hoi Koo, Hye-Young Kim, Jae-Young Lim
    Annals of Geriatric Medicine and Research.2020; 24(4): 267.     CrossRef
  • Mortality is not increased with Diabetes in hospitalised very old adults: a multi-site review
    Peter Smerdely
    BMC Geriatrics.2020;[Epub]     CrossRef
  • Falls and Fractures in Diabetes—More than Bone Fragility
    Nicklas Højgaard Rasmussen, Jakob Dal
    Current Osteoporosis Reports.2019; 17(3): 147.     CrossRef
  • Measuring gait speed to better identify prodromal dementia
    Giulia Grande, Federico Triolo, Arturo Nuara, Anna-Karin Welmer, Laura Fratiglioni, Davide L. Vetrano
    Experimental Gerontology.2019; 124: 110625.     CrossRef
  • Diabetes and Muscle Dysfunction in Older Adults
    Hak Chul Jang
    Annals of Geriatric Medicine and Research.2019; 23(4): 160.     CrossRef
  • Association between sarcopenia and diabetes in community dwelling elderly in the Amazon region – Viver Mais Project
    Anelza Biene Farias Souza, David Anchieta Costa Nascimento, Isabella Juliana Manfredo Rodrigues, Cynthia Cillene Oliveira Charone, Geovanna Lemos Lopes, Rondinei Silva Lima, Ana Amália Sá, Thiago Xavier Carneiro, Niele Silva Moraes
    Archives of Gerontology and Geriatrics.2019; 83: 121.     CrossRef
  • Association between deterioration in muscle strength and peripheral neuropathy in people with diabetes
    Tae Jung Oh, Sunyoung Kang, Jie-Eun Lee, Jae Hoon Moon, Sung Hee Choi, Soo Lim, Hak Chul Jang
    Journal of Diabetes and its Complications.2019; 33(8): 598.     CrossRef
  • Frailty and Disability in Diabetes
    Sol-Ji Yoon, Kwang-il Kim
    Annals of Geriatric Medicine and Research.2019; 23(4): 165.     CrossRef
  • Mechanisms Involved in Glycemic Control Promoted by Exercise in Diabetics
    Eric Francelino Andrade, Víviam de Oliveira Silva, Débora Ribeiro Orlando, Luciano José Pereira
    Current Diabetes Reviews.2019; 15(2): 105.     CrossRef
  • Response: The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity (J Obes Metab Syndr 2019;28:46-52)
    Bo Kyung Koo
    Journal of Obesity & Metabolic Syndrome.2019; 28(4): 297.     CrossRef
  • Diabetic Peripheral Neuropathy as a Risk Factor for Sarcopenia
    Tae Jung Oh, Yoojung Song, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang
    Annals of Geriatric Medicine and Research.2019; 23(4): 170.     CrossRef
  • Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis
    Yunli Zhao, Yunxia Zhang, Qiukui Hao, Meiling Ge, Birong Dong
    Aging Clinical and Experimental Research.2019; 31(1): 5.     CrossRef
  • The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity
    Bo Kyung Koo
    Journal of Obesity & Metabolic Syndrome.2019; 28(1): 46.     CrossRef
  • Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors
    Yuko Murata, Yoshiki Kadoya, Shoichi Yamada, Tokio Sanke
    Diabetology International.2018; 9(2): 136.     CrossRef
  • Assessment of lower extremity muscle mass, muscle strength, and exercise therapy in elderly patients with diabetes mellitus
    Takuo Nomura, Toshihiro Kawae, Hiroaki Kataoka, Yukio Ikeda
    Environmental Health and Preventive Medicine.2018;[Epub]     CrossRef
  • Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine
    Willy Marcos Valencia, Diana Botros, Maria Vera-Nunez, Stuti Dang
    Current Diabetes Reports.2018;[Epub]     CrossRef
  • Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus
    Mariana Murea, Leon Lenchik, Thomas C. Register, Gregory B. Russell, Jianzhao Xu, S. Carrie Smith, Donald W. Bowden, Jasmin Divers, Barry I. Freedman
    Journal of Diabetes and its Complications.2018; 32(6): 558.     CrossRef
  • Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis
    Jae Yoon Jeong, Sanghyeok Lim, Joo Hyun Sohn, Jae Gon Lee, Dae Won Jun, Yongsoo Kim
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Comparison between Dual-Energy X-ray Absorptiometry and Bioelectrical Impedance Analyses for Accuracy in Measuring Whole Body Muscle Mass and Appendicular Skeletal Muscle Mass
    Seo Young Lee, Soyeon Ahn, Young Ji Kim, Myoung Jin Ji, Kyoung Min Kim, Sung Hee Choi, Hak Chul Jang, Soo Lim
    Nutrients.2018; 10(6): 738.     CrossRef
  • The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS)
    Tae Nyun Kim, Man Sik Park, Eun Joo Lee, Hye Soo Chung, Hye Jin Yoo, Hyun Joo Kang, Wook Song, Sei Hyun Baik, Kyung Mook Choi
    Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
  • Obesity paradox on the survival of elderly patients with diabetes: an AHAP-based study
    Ali Bijani, Robert G. Cumming, Seyed-Reza Hosseini, Masoumeh Yazdanpour, Mahdis Rahimi, Abbas Sahebian, Reza Ghadimi
    Journal of Diabetes & Metabolic Disorders.2018; 17(1): 45.     CrossRef
  • Effects of Seahorse Supplementation on Muscle Mass, Exercise Performance Abilities and the Related Blood Factors in Healthy Elderly Women
    Bae-jin LEE, Chan-ho PARK, Byeong-Hwan JEON
    JOURNAL OF FISHRIES AND MARINE SCIENCES EDUCATION.2018; 30(2): 409.     CrossRef
  • Frailty risk in hospitalised older adults with and without diabetes mellitus
    Deborah A. Lekan, Thomas P. McCoy
    Journal of Clinical Nursing.2018; 27(19-20): 3510.     CrossRef
  • Sarcopenia
    А.А. Пальцын
    ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia».2018; (2()): 113.     CrossRef
  • Prevention of Falls and Frailty in Older Adults with Diabetes
    Helen P. Hazuda, Sara E. Espinoza
    Current Geriatrics Reports.2017; 6(3): 158.     CrossRef
  • Patterns and Predictors of Frailty Transitions in Older Men: The Osteoporotic Fractures in Men Study
    Lauren R. Pollack, Stephanie Litwack‐Harrison, Peggy M. Cawthon, Kristine Ensrud, Nancy E. Lane, Elizabeth Barrett‐Connor, Thuy‐Tien Dam
    Journal of the American Geriatrics Society.2017; 65(11): 2473.     CrossRef
  • Diabetic Neuropathy and Gait: A Review
    Uazman Alam, David R. Riley, Ravinder S. Jugdey, Shazli Azmi, Satyan Rajbhandari, Kristiaan D’Août, Rayaz A. Malik
    Diabetes Therapy.2017; 8(6): 1253.     CrossRef
  • Care of older people with diabetes
    Trisha Dunning
    Nursing Standard.2017; 32(3): 50.     CrossRef
  • Decreased Muscle Strength and Quality in Diabetes-Related Dementia
    Akito Tsugawa, Yusuke Ogawa, Naoto Takenoshita, Yoshitsugu Kaneko, Hirokuni Hatanaka, Eriko Jaime, Raita Fukasawa, Haruo Hanyu
    Dementia and Geriatric Cognitive Disorders Extra.2017; 7(3): 454.     CrossRef
  • Aging of the endocrine system and its potential impact on sarcopenia
    Giovanni Vitale, Matteo Cesari, Daniela Mari
    European Journal of Internal Medicine.2016; 35: 10.     CrossRef
Editorial
Complications
Hypoglycemia: Culprit or Bystander?
You-Cheol Hwang
Diabetes Metab J. 2016;40(3):190-191.   Published online June 20, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.190
  • 2,833 View
  • 28 Download
PDFPubReader   
Original Articles
Clinical Care/Education
Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study
Eun Ky Kim, Soo Heon Kwak, Seungsu Baek, Seung Lyeol Lee, Hak Chul Jang, Kyong Soo Park, Young Min Cho
Diabetes Metab J. 2016;40(3):192-201.   Published online April 8, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.192
  • 6,200 View
  • 61 Download
  • 23 Web of Science
  • 29 Crossref
AbstractAbstract PDFPubReader   
Background

We developed a patient-centered, smartphone-based, diabetes care system (PSDCS). This study aims to test the feasibility of glycosylated hemoglobin (HbA1c) reduction with the PSDCS.

Methods

This study was a single-arm pilot study. The participants with type 2 diabetes mellitus were instructed to use the PSDCS, which integrates a Bluetooth-connected glucometer, digital food diary, and wearable physical activity monitoring device. The primary end point was the change in HbA1c from baseline after a 12-week intervention.

Results

Twenty-nine patients aged 53.9±9.1 years completed the study. HbA1c and fasting plasma glucose levels decreased significantly from baseline (7.7%±0.7% to 7.1%±0.6%, P<0.0001; 140.9±39.1 to 120.1±31.0 mg/dL, P=0.0088, respectively). The frequency of glucose monitoring correlated with the magnitude of HbA1c reduction (r=–0.57, P=0.0013). The components of the diabetes self-care activities, including diet, exercise, and glucose monitoring, were significantly improved, particularly in the upper tertile of HbA1c reduction. There were no severe adverse events during the intervention.

Conclusion

A 12-week application of the PSDCS to patients with inadequately controlled type 2 diabetes resulted in a significant HbA1c reduction with tolerable safety profiles; these findings require confirmation in a future randomized controlled trial.

Citations

Citations to this article as recorded by  
  • Telehealth Technologies in Diabetes Self-management and Education
    Vidya Sharma, Marie Feldman, Ramaswamy Sharma
    Journal of Diabetes Science and Technology.2024; 18(1): 148.     CrossRef
  • Analysis and mapping the research landscape on patient‐centred care in the context of chronic disease management
    Waleed M. Sweileh
    Journal of Evaluation in Clinical Practice.2024; 30(4): 638.     CrossRef
  • Effects of a diabetes education program integrated with text-message support for lifestyle change among older individuals with type 2 diabetes in communities: a randomised controlled trial
    M. Hou, W.N. Qiu, H.L. Qi, H.X. Shao, J.M. Yu, H.Y. Bian
    Public Health.2024; 235: 152.     CrossRef
  • App Design Features Important for Diabetes Self-management as Determined by the Self-Determination Theory on Motivation: Content Analysis of Survey Responses From Adults Requiring Insulin Therapy
    Helen N C Fu, Jean F Wyman, Cynthia J Peden-McAlpine, Claire Burke Draucker, Titus Schleyer, Terrence J Adam
    JMIR Diabetes.2023; 8: e38592.     CrossRef
  • The Clinical Impact of Flash Glucose Monitoring—a Digital Health App and Smartwatch Technology in Patients With Type 2 Diabetes: Scoping Review
    Sergio Diez Alvarez, Antoni Fellas, Derek Santos, Dean Sculley, Katie Wynne, Shamasunder Acharya, Pooshan Navathe, Xavier Girones, Andrea Coda
    JMIR Diabetes.2023; 8: e42389.     CrossRef
  • User Retention and Engagement in the Digital-Based Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (myDESMOND) Program: Descriptive Longitudinal Study
    Mary M Barker, Radhika Chauhan, Melanie J Davies, Christopher Brough, Alison Northern, Bernie Stribling, Sally Schreder, Kamlesh Khunti, Michelle Hadjiconstantinou
    JMIR Diabetes.2023; 8: e44943.     CrossRef
  • The role of SmartWatch Technology in the provision of care for type 1 or 2 Diabetes Mellitus or Gestational Diabetes: a systematic review. (Preprint)
    Sergio Alvarez, Antoni Fellas, Katie Wynne, Derek Santos, Dean Sculley, Shamasunder Acharya, Pooshan Navathe, Xavier Girones, Andrea Coda
    JMIR mHealth and uHealth.2023;[Epub]     CrossRef
  • Wearable Devices for Supporting Chronic Disease Self-Management: A Scoping Review (Preprint)
    Marie-Pierre Gagnon, Steven Ouellet, Eugène Attisso, Wilfried Supper, Samira Amil, Caroline Rhéaume, Jean-Sébastien Paquette, Christian Chabot, Marie-Claude Laferrière, Maxime Sasseville
    Interactive Journal of Medical Research.2023;[Epub]     CrossRef
  • New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 Diabetes
    David Kerr, Steven Edelman, Giacomo Vespasiani, Kamlesh Khunti
    Endocrine Practice.2022; 28(8): 811.     CrossRef
  • Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study
    Hun Jee Choe, Eun-Jung Rhee, Jong Chul Won, Kyong Soo Park, Won-Young Lee, Young Min Cho
    Diabetes Care.2022; 45(10): 2224.     CrossRef
  • Assessing the Acceptability and Effectiveness of Mobile-Based Physical Activity Interventions for Midlife Women During Menopause: Systematic Review of the Literature
    Ghada AlSwayied, Haoyue Guo, Tasmin Rookes, Rachael Frost, Fiona L Hamilton
    JMIR mHealth and uHealth.2022; 10(12): e40271.     CrossRef
  • Application of the National Institute for Health and Care Excellence Evidence Standards Framework for Digital Health Technologies in Assessing Mobile-Delivered Technologies for the Self-Management of Type 2 Diabetes Mellitus: Scoping Review
    Jessica R Forsyth, Hannah Chase, Nia W Roberts, Laura C Armitage, Andrew J Farmer
    JMIR Diabetes.2021; 6(1): e23687.     CrossRef
  • Mobile Healthcare System Provided by Primary Care Physicians Improves Quality of Diabetes Care
    Tae Jung Oh, Jie-Eun Lee, Seok Kim, Sooyoung Yoo, Hak Chul Jang
    CardioMetabolic Syndrome Journal.2021; 1(1): 88.     CrossRef
  • Self-Care IoT Platform for Diabetic Mellitus
    Jai-Chang Park, Seongbeom Kim, Je-Hoon Lee
    Applied Sciences.2021; 11(5): 2006.     CrossRef
  • Diabetes clinic reinvented: will technology change the future of diabetes care?
    Marwa Al-Badri, Osama Hamdy
    Therapeutic Advances in Endocrinology and Metabolism.2021;[Epub]     CrossRef
  • Analysis of Effectiveness and Psychological Techniques Implemented in mHealth Solutions for Middle-Aged and Elderly Adults with Type 2 Diabetes: A Narrative Review of the Literature
    Julia Vázquez-de Sebastián, Andreea Ciudin, Carmina Castellano-Tejedor
    Journal of Clinical Medicine.2021; 10(12): 2701.     CrossRef
  • Therapeutic Exercise Platform for Type-2 Diabetic Mellitus
    Je-Hoon Lee, Jai-Chang Park, Seong-Beom Kim
    Electronics.2021; 10(15): 1820.     CrossRef
  • Accuracy comparison study of new smartphone-based semen analyzer versus laboratory sperm quality analyzer
    Min Jung Park, Mi Young Lim, Hyun Jun Park, Nam Cheol Park
    Investigative and Clinical Urology.2021; 62(6): 672.     CrossRef
  • User Retention and Engagement With a Mobile App Intervention to Support Self-Management in Australians With Type 1 or Type 2 Diabetes (My Care Hub): Mixed Methods Study
    Mary D Adu, Usman H Malabu, Aduli EO Malau-Aduli, Aaron Drovandi, Bunmi S Malau-Aduli
    JMIR mHealth and uHealth.2020; 8(6): e17802.     CrossRef
  • The role of telehealth counselling with mobile self-monitoring on blood pressure reduction among overseas Koreans with high blood pressure in Vietnam
    Hyang Yuol Lee, Ju Young Kim, Ki Young Na, Hwa Yeon Park, Jinah Han, Yuliya Pak, Bola Nam, Chae Hyun Pae, Jisun Lee, Tae Ho Lim, Donghun Lee
    Journal of Telemedicine and Telecare.2019; 25(4): 241.     CrossRef
  • The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks
    Eun Ky Kim, Soo Heon Kwak, Hye Seung Jung, Bo Kyung Koo, Min Kyong Moon, Soo Lim, Hak Chul Jang, Kyong Soo Park, Young Min Cho
    Diabetes Care.2019; 42(1): 3.     CrossRef
  • Patient-Driven Diabetes Care of the Future in the Technology Era
    Sahar Ashrafzadeh, Osama Hamdy
    Cell Metabolism.2019; 29(3): 564.     CrossRef
  • Peripartum Management of Gestational Diabetes Using a Digital Health Care Service: A Pilot, Randomized Controlled Study
    Ji-Hee Sung, Da Young Lee, Kyoung Pil Min, Cheol-Young Park
    Clinical Therapeutics.2019; 41(11): 2426.     CrossRef
  • The Effects of Dietary Mobile Apps on Nutritional Outcomes in Adults with Chronic Diseases: A Systematic Review and Meta-Analysis
    Cosette Fakih El Khoury, Mirey Karavetian, Ruud J.G. Halfens, Rik Crutzen, Lama Khoja, Jos M.G.A. Schols
    Journal of the Academy of Nutrition and Dietetics.2019; 119(4): 626.     CrossRef
  • Diabetes Mellitus m-Health Applications: A Systematic Review of Features and Fundamentals
    Ericles Andrei Bellei, Daiana Biduski, Nathália Pinto Cechetti, Ana Carolina Bertoletti De Marchi
    Telemedicine and e-Health.2018; 24(11): 839.     CrossRef
  • Multifunctional Wearable System that Integrates Sweat‐Based Sensing and Vital‐Sign Monitoring to Estimate Pre‐/Post‐Exercise Glucose Levels
    Yongseok Joseph Hong, Hyunjae Lee, Jaemin Kim, Minha Lee, Hyung Jin Choi, Taeghwan Hyeon, Dae‐Hyeong Kim
    Advanced Functional Materials.2018;[Epub]     CrossRef
  • Smart Devices for Older Adults Managing Chronic Disease: A Scoping Review
    Ben YB Kim, Joon Lee
    JMIR mHealth and uHealth.2017; 5(5): e69.     CrossRef
  • Usability and clinical efficacy of diabetes mobile applications for adults with type 2 diabetes: A systematic review
    Helen Fu, Siobhan K. McMahon, Cynthia R. Gross, Terrence J. Adam, Jean F. Wyman
    Diabetes Research and Clinical Practice.2017; 131: 70.     CrossRef
  • Novel device for male infertility screening with single-ball lens microscope and smartphone
    Yoshitomo Kobori, Peter Pfanner, Gail S. Prins, Craig Niederberger
    Fertility and Sterility.2016; 106(3): 574.     CrossRef
Complications
Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
Seon-Ah Cha, Jae-Seung Yun, Tae-Seok Lim, Seawon Hwang, Eun-Jung Yim, Ki-Ho Song, Ki-Dong Yoo, Yong-Moon Park, Yu-Bae Ahn, Seung-Hyun Ko
Diabetes Metab J. 2016;40(3):202-210.   Published online April 5, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.202
  • 5,245 View
  • 65 Download
  • 50 Web of Science
  • 58 Crossref
AbstractAbstract PDFPubReader   
Background

We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or all-cause mortality in patients with type 2 diabetes.

Methods

The study included 1,260 patients aged 25 to 75 years with type 2 diabetes from the Vincent Type 2 Diabetes Resgistry (VDR), who consecutively enrolled (n=1,260) from January 2000 to December 2010 and were followed up until May 2015 with a median follow-up time of 10.4 years. Primary outcomes were death from any cause or CV death. We investigated the association between the CV or all-cause mortality and various covariates using Cox proportional hazards regression analysis.

Results

Among the 906 participants (71.9%) who completed follow-up, 85 patients (9.4%) had at least one episode of SH, and 86 patients (9.5%) died (9.1 per 1,000 patient-years). Patients who had died were older, had a longer duration of diabetes and hypertension, received more insulin, and had more diabetic microvascular complications at baseline, as compared with surviving patients. The experience of SH was significantly associated with an increased risk of all-cause mortality (hazard ratio [HR], 2.64; 95% confidence interval [CI], 1.39 to 5.02; P=0.003) and CV mortality (HR, 6.34; 95% CI, 2.02 to 19.87; P=0.002) after adjusting for sex, age, diabetic duration, hypertension, mean glycosylated hemoglobin levels, diabetic nephropathy, lipid profiles, and insulin use.

Conclusion

We found a strong association between SH and increased risk of all-cause and CV mortality in patients with type 2 diabetes.

Citations

Citations to this article as recorded by  
  • Impaired Awareness of Hypoglycemia and its Risk Factors among Diabetic Patients in Jazan, Saudi Arabia: A Cross-Sectional Study
    Omar Oraibi, Abdulelah Alameer, Mohammed Dalak, Sawsan Alsharif, Shatha A. Hakami, Mohammed Sumayli, Ayman Shami, Mostafa Mohrag, Mohammed A. Madkhali, Mohammed Ali Madkhali, Luai Alhazmi, Majid Darraj
    Current Diabetes Reviews.2024;[Epub]     CrossRef
  • The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
    Lei Ding, Hongda Zhang, Cong Dai, Aikai Zhang, Fengyuan Yu, Lijie Mi, Yingjie Qi, Min Tang
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Navigating the future of diabetes: innovative nomogram models for predicting all-cause mortality risk in diabetic nephropathy
    Sensen Wu, Hui Wang, Dikang Pan, Julong Guo, Fan Zhang, Yachan Ning, Yongquan Gu, Lianrui Guo
    BMC Nephrology.2024;[Epub]     CrossRef
  • Association of hypoglycaemia with the risks of arrhythmia and mortality in individuals with diabetes - a systematic review and meta-analysis
    Gangfeng Li, Shuping Zhong, Xingmu Wang, Fuyuan Zhuge
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diabetes mellitus und Straßenverkehr – ein Positionspapier der Österreichischen Diabetesgesellschaft (Update 2023)
    Heidemarie Abrahamian, Birgit Salamon, Angelika Lahnsteiner, Christian Schelkshorn, Alexander Bräuer, Lars Stechemesser, Gerd Köhler, Martin Clodi
    Wiener klinische Wochenschrift.2023; 135(S1): 319.     CrossRef
  • Validation of the hypoglycemia awareness questionnaire to assess hypoglycemia awareness in patients with type 2 diabetes treated with insulin
    Diana Cristina Henao-Carrillo, Fabio Alexander Sierra-Matamoros, Ana Julia Carrillo Algarra, Julieth Patricia García-Lugo, Sandra Milena Hernández-Zambrano
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(12): 102917.     CrossRef
  • Basal insulin analogues in people with diabetes and chronic kidney disease
    David León‐Jiménez, José Pablo Miramontes‐González, Laura Márquez‐López, Francisco Astudillo‐Martín, Luis M. Beltrán‐Romero, Fernando Moreno‐Obregón, Javier Escalada‐San Martín
    Diabetic Medicine.2022;[Epub]     CrossRef
  • Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study
    Eugene Han, Kyung-do Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung-Hyun Ko, Yong-ho Lee
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): e1976.     CrossRef
  • Validación transcultural del HypoA-Q para medir conciencia de hipoglucemia en pacientes diabéticos
    Ana Julia Carrillo-Algarra, Sandra Milena Hernandez-Zambrano, Fabio Alexander Sierra-Matamoros, Diana Cristina Henao-Carrillo, Ana María Gómez-Medina, Daniel Esteban Hurtado-Barrera
    Revista Ciencia y Cuidado.2022; 19(1): 42.     CrossRef
  • Validity of the diagnosis of diabetic microvascular complications in Korean national health insurance claim data
    Hyung Jun Kim, Moo-Seok Park, Jee-Eun Kim, Tae-Jin Song
    Annals of Clinical Neurophysiology.2022; 24(1): 7.     CrossRef
  • Severe hypoglycemia as a risk factor for cardiovascular outcomes in patients with type 2 diabetes: is it preventable?
    Seung-Hyun Ko
    Cardiovascular Prevention and Pharmacotherapy.2022; 4(3): 106.     CrossRef
  • Evaluation of a Clinical Platform to Promote Chronic Disease Management
    Laura Greene, Nila Sathe, John A. House, Laura L. Schott, Stella Safo
    Population Health Management.2021; 24(4): 470.     CrossRef
  • Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
    Soo-Yeon Choi, Seung-Hyun Ko
    The Korean Journal of Internal Medicine.2021; 36(2): 263.     CrossRef
  • Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents
    Katharina Mattishent, Yoon K. Loke
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Epidemiology and outcomes from severe hypoglycemia in Kuwait: a prospective cohort study
    Dalal Al Hasan, Ameen Yaseen, Mohammad Al Roudan, Lee Wallis
    BMC Emergency Medicine.2021;[Epub]     CrossRef
  • The incidence of hypoglycemia and its risk factors among diabetic patients in the Eastern Province of Saudi Arabia
    Ahmed Elshebiny, Hassan Alali, Zainab Alamer, Yasmin Alsultan, Hashim Alkhalaf, Abdullah Alkishi, Mohammed Alsuwaylih
    International Journal of Medicine in Developing Countries.2021; : 614.     CrossRef
  • Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
    Jae-Seung Yun, Seung-Hyun Ko
    Metabolism.2021; 123: 154838.     CrossRef
  • Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand
    Bancha Satirapoj, Thongchai Pratipanawatr, Boonsong Ongphiphadhanakul, Sompongse Suwanwalaikorn, Yupin Benjasuratwong, Wannee Nitiyanant
    BMJ Open.2020; 10(2): e031612.     CrossRef
  • Predictors of Diabetes Self-Care Practice Among Patients with Type 2 Diabetes in Public Hospitals in Northeastern Ethiopia: A Facility-Based Cross-Sectional Study


    Tesfaye Molla Gulentie, Ebrahim Mohammed Yesuf, Taklo Simeneh Yazie, Belayneh Kefale
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 3137.     CrossRef
  • Hypoglycemia in Older Patients
    Byron J. Hoogwerf
    Clinics in Geriatric Medicine.2020; 36(3): 395.     CrossRef
  • Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
    Francesco Zaccardi, Suping Ling, Claire Lawson, Melanie J. Davies, Kamlesh Khunti
    Diabetologia.2020; 63(10): 2129.     CrossRef
  • Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4
    Carolina C. Betônico, Silvia Maria O. Titan, Aécio Lira, Tatiana S. Pelaes, Maria Lúcia C. Correa-Giannella, Márcia Nery, Márcia Queiroz
    Clinical Therapeutics.2019; 41(10): 2008.     CrossRef
  • Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478)
    Athena Philis-Tsimikas, Irene Stratton, Lone Nørgård Troelsen, Britta Anker Bak, Lawrence A. Leiter
    Journal of Diabetes Science and Technology.2019; 13(3): 498.     CrossRef
  • Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes
    Yehuda Handelsman, Christina Chovanes, Terry Dex, Francesco Giorgino, Neil Skolnik, Elisabeth Souhami, William Stager, Elisabeth Niemoeller, Juan Pablo Frias
    Journal of Diabetes and its Complications.2019; 33(3): 236.     CrossRef
  • Urinary glucose excretion after dapagliflozin treatment: An exposure‐response modelling comparison between Japanese and non‐Japanese patients diagnosed with type 1 diabetes mellitus
    Victor Sokolov, Tatiana Yakovleva, Shinya Ueda, Joanna Parkinson, David W. Boulton, Robert C. Penland, Weifeng Tang
    Diabetes, Obesity and Metabolism.2019; 21(4): 829.     CrossRef
  • Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population‐based, propensity‐score‐matched cohort study
    Shihchen Kuo, Chun‐Ting Yang, Jin‐Shang Wu, Huang‐Tz Ou
    Diabetes, Obesity and Metabolism.2019; 21(2): 312.     CrossRef
  • Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)
    Richard E. Pratley, Scott S. Emerson, Edward Franek, Matthew P. Gilbert, Steven P. Marso, Darren K. McGuire, Thomas R. Pieber, Bernard Zinman, Charlotte T. Hansen, Melissa V. Hansen, Thomas Mark, Alan C. Moses, John B. Buse
    Diabetes, Obesity and Metabolism.2019; 21(7): 1625.     CrossRef
  • Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial
    Marile Santamarina, Curt J. Carlson
    BMC Cardiovascular Disorders.2019;[Epub]     CrossRef
  • Effects of a 12-week moderate-intensity exercise training on blood glucose response in patients with type 2 diabetes
    Shang-Lin Chiang, Margaret McLean Heitkemper, Yi-Jen Hung, Wen-Chii Tzeng, Meei-Shyuan Lee, Chia-Huei Lin
    Medicine.2019; 98(36): e16860.     CrossRef
  • Impaired Awareness of Hypoglycaemia in Insulin-treated Type 2 Diabetes Mellitus
    Mohammad J. Alkhatatbeh, Nedaa A. Abdalqader , Mohammad A.Y. Alqudah
    Current Diabetes Reviews.2019; 15(5): 407.     CrossRef
  • Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
    Stephanie A Amiel, Pablo Aschner, Belinda Childs, Philip E Cryer, Bastiaan E de Galan, Brian M Frier, Linda Gonder-Frederick, Simon R Heller, Timothy Jones, Kamlesh Khunti, Lawrence A Leiter, Yingying Luo, Rory J McCrimmon, Ulrik Pedersen-Bjergaard, Eliza
    The Lancet Diabetes & Endocrinology.2019; 7(5): 385.     CrossRef
  • Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study
    Kristian B. Filion, Antonios Douros, Laurent Azoulay, Hui Yin, Oriana H. Yu, Samy Suissa
    British Journal of Clinical Pharmacology.2019; 85(10): 2378.     CrossRef
  • Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study
    F. Zaccardi, L.L. Nystrup Husemoen, B.L. Thorsted, D.R. Webb, S.K. Paul, M.J. Davies, K. Khunti
    Nutrition, Metabolism and Cardiovascular Diseases.2019; 29(5): 481.     CrossRef
  • Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime
    Fangfang Jiao, Eric Yuk Fai Wan, Colman Siu Cheung Fung, Anca Ka Chun Chan, Sarah Morag McGhee, Ruby Lai Ping Kwok, Cindy Lo Kuen Lam
    Endocrine.2019; 63(2): 259.     CrossRef
  • Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend
    Ana María Gómez, Diana Cristina Henao, Angelica Imitola, Oscar Mauricio Muñoz, Martín Alonso Rondón Sepúlveda, Laura Kattah, Juan Sebastian Guerrero, Elly Morros, Juan Pablo Llano, Maira García Jaramillo, Fabián León-Vargas
    Endocrinología, Diabetes y Nutrición.2018; 65(8): 451.     CrossRef
  • Recent diabetes-related mortality trends in Romania
    Sorin Ioacara, Elisabeta Sava, Olivia Georgescu, Anca Sirbu, Simona Fica
    Acta Diabetologica.2018; 55(8): 821.     CrossRef
  • Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia
    D. A. Lebedev, A. Yu. Babenko
    Medical Council.2018; (16): 100.     CrossRef
  • Severe hypoglycemia is a risk factor for atrial fibrillation in type 2 diabetes mellitus: Nationwide population-based cohort study
    Seung-Hyun Ko, Yong-Moon Park, Jae-Seung Yun, Seon-Ah Cha, Eue-Keun Choi, Kyungdo Han, Eugene Han, Yong-ho Lee, Yu-Bae Ahn
    Journal of Diabetes and its Complications.2018; 32(2): 157.     CrossRef
  • Antioxidant effects of epigallocatechin-3-gallate on the aTC1-6 pancreatic alpha cell line
    Ting Cao, Xiong Zhang, Dan Yang, Yue-Qian Wang, Zheng-Dong Qiao, Jian-Ming Huang, Peng Zhang
    Biochemical and Biophysical Research Communications.2018; 495(1): 693.     CrossRef
  • Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study
    Mee Kyoung Kim, Jee Sun Jeong, Jae-Seung Yun, Hyuk-Sang Kwon, Ki Hyun Baek, Ki-Ho Song, Yu-Bae Ahn, Seung-Hyun Ko
    Journal of Diabetes and its Complications.2018; 32(10): 906.     CrossRef
  • Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
    Bernard Zinman, Steven P. Marso, Neil R. Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco, Jesper Barner Lekdorf, Kajsa Kvist, John B. Buse
    Diabetologia.2018; 61(1): 48.     CrossRef
  • Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend
    Ana María Gómez, Diana Cristina Henao, Angelica Imitola, Oscar Mauricio Muñoz, Martín Alonso Rondón Sepúlveda, Laura Kattah, Juan Sebastian Guerrero, Elly Morros, Juan Pablo Llano, Maira García Jaramillo, Fabián León-Vargas
    Endocrinología, Diabetes y Nutrición (English ed.).2018; 65(8): 451.     CrossRef
  • Time- and frequency-domain measures of heart rate variability predict cardiovascular outcome in patients with type 2 diabetes
    Seon-Ah Cha, Yong-Moon Park, Jae-Seung Yun, Seung-Hwan Lee, Yu-Bae Ahn, Sung-Rae Kim, Seung-Hyun Ko
    Diabetes Research and Clinical Practice.2018; 143: 159.     CrossRef
  • Newly diagnosed type 2 diabetes in an ethnic minority population: clinical presentation and comparison to other populations
    Michael Morkos, Bettina Tahsin, Louis Fogg, Leon Fogelfeld
    BMJ Open Diabetes Research & Care.2018; 6(1): e000568.     CrossRef
  • DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
    Thomas R. Pieber, Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R. Poulter, Scott S. Emerson, Richard E. Pratley, Vincent Woo, Simon Heller, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Jesper Barner Lekdorf, Lucine Lehmann, Kajsa Kvist,
    Diabetologia.2018; 61(1): 58.     CrossRef
  • Intervention effects of Compound Houttuyniae Herba to diabetic renal damage based on SOCS-JAK/STAT negative feedback regulation
    Yun Fang, Sai-cong Shao, Hai-ying Wang
    Chinese Herbal Medicines.2018; 10(4): 424.     CrossRef
  • Monotherapy in Patients with Type 2 Diabetes Mellitus
    Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
    Diabetes & Metabolism Journal.2017; 41(5): 349.     CrossRef
  • Monotherapy in patients with type 2 diabetes mellitus
    Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
    The Korean Journal of Internal Medicine.2017; 32(6): 959.     CrossRef
  • Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
    Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
    The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
  • Cardiovascular effects of dipeptidyl peptidase-4 inhibitor in diabetic patients with and without established cardiovascular disease: a meta-analysis and systematic review
    Shishi Xu, Xinyue Zhang, Lizhi Tang, Fang Zhang, Nanwei Tong
    Postgraduate Medicine.2017; 129(2): 205.     CrossRef
  • Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
    Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
    Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
  • Effects of propofol on myocardial ischemia-reperfusion injury in rats with type-2 diabetes mellitus
    Ying Wang, Xiuru Qi, Chunliang Wang, Danning Zhao, Hongjie Wang, Jianxin Zhang
    Biomedical Reports.2017; 6(1): 69.     CrossRef
  • Cardiovascular risk assessment in patients with diabetes
    Marcello Casaccia Bertoluci, Viviane Zorzanelli Rocha
    Diabetology & Metabolic Syndrome.2017;[Epub]     CrossRef
  • Pathogenetic features of the combined course of arterial hypertension and diabetes mellitus 2 type
    O.M. Bilovol, L.R. Bobronnikova, O.V. Al-Trawneh
    Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini.2017; 2017(1): 4.     CrossRef
  • Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
    Jae-Seung Yun, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2016; 40(6): 423.     CrossRef
  • Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study
    Koutaro Yokote, Yasuo Terauchi, Ichiro Nakamura, Haruko Sugamori
    Expert Opinion on Pharmacotherapy.2016; 17(15): 1995.     CrossRef
  • Hypoglycemia: Culprit or Bystander?
    You-Cheol Hwang
    Diabetes & Metabolism Journal.2016; 40(3): 190.     CrossRef
  • Schwere Hypoglykämien erhöhen die Mortalität
    E. Fritschka
    MMW - Fortschritte der Medizin.2016; 158(S3): 46.     CrossRef
Complications
Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice
Gwon-Soo Jung, Jae-Han Jeon, Mi Sun Choe, Sung-Woo Kim, In-Kyu Lee, Mi-Kyung Kim, Keun-Gyu Park
Diabetes Metab J. 2016;40(3):211-221.   Published online March 31, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.211
  • 7,061 View
  • 57 Download
  • 24 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   
Background

Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used in the treatment of patients with type 2 diabetes and have proven protective effects on diabetic kidney disease (DKD). Whether DPP-4 inhibitors have renoprotective effects on insulin-deficient type 1 diabetes has not been comprehensively examined. The aim of this study was to determine whether gemigliptin, a new DPP-4 inhibitor, has renoprotective effects in streptozotocin (STZ)-induced type 1 diabetic mice.

Methods

Diabetes was induced by intraperitoneal administration of a single dose of STZ. Mice with diabetes were treated without or with gemigliptin (300 mg/kg) for 8 weeks. Morphological changes of the glomerular basement membrane (GBM) were observed by electron microscopy and periodic-acid Schiff staining. In addition, we measured blood glucose and urinary albumin excretion and evaluated fibrotic markers using immunohistochemical staining, quantitative reverse transcription polymerase chain reaction analysis, and Western blot analysis.

Results

Gemigliptin did not reduce the blood glucose levels of STZ-treated mice. In gemigliptin-treated mice with STZ, a significant reduction in urinary albumin excretion and GBM thickness was observed. Immunohistological examination revealed that gemigliptin attenuated renal fibrosis induced by STZ and decreased extracellular matrix protein levels, including those of type I collagen and fibronectin, and Smad3 phosphorylation. In cultured rat renal cells, gemigliptin inhibited transforming growth factor β-stimulated type I collagen and fibronectin mRNA and protein levels via down-regulation of Smad3 phosphorylation.

Conclusion

Our data demonstrate that gemigliptin has renoprotective effects on DKD, regardless of its glucose-lowering effect, suggesting that it could be used to prevent DKD, including in patients with type 1 diabetes.

Citations

Citations to this article as recorded by  
  • Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin
    Ding-Cheng Chan, Yuan-Cheng Lin, Huei-Ping Tzeng, Rong-Sen Yang, Meng-Tsan Chiang, Shing-Hwa Liu
    Tissue and Cell.2024; 89: 102479.     CrossRef
  • Gemigliptin mitigates TGF-β-induced renal fibrosis through FGF21-mediated inhibition of the TGF-β/Smad3 signaling pathway
    Jun-Kyu Byun, Gwon-Soo Jung
    Biochemical and Biophysical Research Communications.2024; 733: 150425.     CrossRef
  • Safety and Efficiency of Dipeptidyl Peptidase IV Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
    Adili Tuersun, Munire Mohetaer, Guanxin Hou, Gang Cheng
    Current Therapeutic Research.2024; 101: 100763.     CrossRef
  • Diabetic fibrosis
    Izabela Tuleta, Nikolaos G. Frangogiannis
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2021; 1867(4): 166044.     CrossRef
  • Protective roles of thymoquinone and vildagliptin in manganese-induced nephrotoxicity in adult albino rats
    Heba El-Sayed Mostafa, Eman Ahmed Alaa El-Din, Dalia Abdallah El-Shafei, Nehal S. Abouhashem, Aisha Abdallah Abouhashem
    Environmental Science and Pollution Research.2021; 28(24): 31174.     CrossRef
  • Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
    Mi-Jin Kim, Na-young Kim, Yun-A Jung, Seunghyeong Lee, Gwon-Soo Jung, Jung-Guk Kim, In-Kyu Lee, Sungwoo Lee, Yeon-Kyung Choi, Keun-Gyu Park
    Diabetes & Metabolism Journal.2020; 44(1): 186.     CrossRef
  • Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
    Jung Beom Seo, Yeon-Kyung Choi, Hye-In Woo, Yun-A Jung, Sungwoo Lee, Seunghyeong Lee, Mihyang Park, In-Kyu Lee, Gwon-Soo Jung, Keun-Gyu Park
    Diabetes & Metabolism Journal.2019; 43(6): 830.     CrossRef
  • Recent advances in the pathogenesis of microvascular complications in diabetes
    Sungmi Park, Hyeon-Ji Kang, Jae-Han Jeon, Min-Ji Kim, In-Kyu Lee
    Archives of Pharmacal Research.2019; 42(3): 252.     CrossRef
  • Diabetic nephropathy: An update on pathogenesis and drug development
    Vikram Rao A/L B Vasanth Rao, Sean Hong Tan, Mayuren Candasamy, Subrat Kumar Bhattamisra
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 754.     CrossRef
  • Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
    Katarina Tomovic, Jelena Lazarevic, Gordana Kocic, Marina Deljanin‐Ilic, Marko Anderluh, Andrija Smelcerovic
    Medicinal Research Reviews.2019; 39(1): 404.     CrossRef
  • Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
    Endocrinology and Metabolism.2019; 34(1): 80.     CrossRef
  • The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes
    Kelly R. McHugh, Adam D. DeVore, Robert J. Mentz, Daniel Edmonston, Jennifer B. Green, Adrian F. Hernandez
    Clinical Cardiology.2018; 41(9): 1259.     CrossRef
  • Acute Kidney Injury and Progression of Diabetic Kidney Disease
    Samuel Mon-Wei Yu, Joseph V. Bonventre
    Advances in Chronic Kidney Disease.2018; 25(2): 166.     CrossRef
  • Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats
    Weiqin Yin, Shiqing Xu, Zai Wang, Honglin Liu, Liang Peng, Qing Fang, Tingting Deng, Wenjian Zhang, Jinning Lou
    Biochemical and Biophysical Research Communications.2018; 495(1): 793.     CrossRef
  • Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice
    Laura E. Crotty Alexander, Christopher A. Drummond, Mark Hepokoski, Denzil Mathew, Alex Moshensky, Andrew Willeford, Soumita Das, Prabhleen Singh, Zach Yong, Jasmine H. Lee, Kevin Vega, Ashley Du, John Shin, Christian Javier, Jiang Tian, Joan Heller Brown
    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2018; 314(6): R834.     CrossRef
  • Renoprotective effect of fucoidan from Acaudina molpadioides in streptozotocin/high fat diet-induced type 2 diabetic mice
    Shiwei Hu, Jinhui Wang, Jingfeng Wang, Shijie Li, Wei Jiang, Yu Liu
    Journal of Functional Foods.2017; 31: 123.     CrossRef
  • Dipeptidyl peptidase-4 inhibition and renoprotection
    Yuta Takagaki, Daisuke Koya, Keizo Kanasaki
    Current Opinion in Nephrology and Hypertension.2017; 26(1): 56.     CrossRef
  • Treatment of diabetic kidney disease: current and future targets
    Mi-Kyung Kim
    The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef
  • Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
    Ewa Otto-Buczkowska, Natalia Jainta
    International Journal of Endocrinology and Metabolism.2017;[Epub]     CrossRef
  • GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
    Marcel H. A. Muskiet, Lennart Tonneijck, Mark M. Smits, Michaël J.B. van Baar, Mark H. H. Kramer, Ewout J. Hoorn, Jaap A. Joles, Daniël H. van Raalte
    Nature Reviews Nephrology.2017; 13(10): 605.     CrossRef
  • Efficacy, safety and albuminuria‐reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12‐week, double‐blind randomized study (the GUARD Study)
    Sun A. Yoon, Byoung G. Han, Sung G. Kim, Sang Y. Han, Young I. Jo, Kyung H. Jeong, Kook H. Oh, Hyeong C. Park, Sun H. Park, Shin W. Kang, Ki R. Na, Sun W. Kang, Nam H. Kim, Young H. Jang, Seong H. Shin, Dae R. Cha
    Diabetes, Obesity and Metabolism.2017; 19(4): 590.     CrossRef
  • Sodium butyrate has context-dependent actions on dipeptidyl peptidase-4 and other metabolic parameters
    Eun-Sol Lee, Dong-Sung Lee, Prakash Raj Pandeya, Youn-Chul Kim, Dae-Gil Kang, Ho-Sub Lee, Byung-Chul Oh, Dae Ho Lee
    The Korean Journal of Physiology & Pharmacology.2017; 21(5): 519.     CrossRef
  • Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
    Kwi-Hyun Bae, Jung Beom Seo, Yun-A Jung, Hye-Young Seo, Sun Hee Kang, Hui-Jeon Jeon, Jae Man Lee, Sungwoo Lee, Jung-Guk Kim, In-Kyu Lee, Gwon-Soo Jung, Keun-Gyu Park
    Endocrinology and Metabolism.2017; 32(1): 115.     CrossRef
  • Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus
    Sung-Ho Kim, Jung-Hwa Yoo, Woo Je Lee, Cheol-Young Park
    Diabetes & Metabolism Journal.2016; 40(5): 339.     CrossRef
  • Risk assessment and management of post-transplant diabetes mellitus
    Eugene Han, Myoung Soo Kim, Yu Seun Kim, Eun Seok Kang
    Metabolism.2016; 65(10): 1559.     CrossRef
Genetics
APO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus
Fariba Koohdani, Haleh Sadrzadeh-Yeganeh, Mahmoud Djalali, Mohammadreza Eshraghian, Elham Zamani, Gity Sotoudeh, Mohammad-Ali Mansournia, Laleh Keramat
Diabetes Metab J. 2016;40(3):222-229.   Published online June 20, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.222
  • 3,683 View
  • 33 Download
  • 12 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   
Background

Apolipoprotein A2 (APO A2) is the second most abundant structural apolipoprotein in high density lipoprotein. Several studies have examined the possible effect of APO A2 on atherosclerosis incidence. Due to the role of inflammation in atherosclerosis, we aimed to determine the relationship between APO A2 -265T/C polymorphism and inflammation as a risk factor in type 2 diabetes mellitus (T2DM) patients.

Methods

In total, 180 T2DM patients, with known APO A2 -265T/C polymorphism, were recruited for this comparative study and were grouped equally based on their genotypes. Dietary intakes, anthropometric parameters, lipid profile, and inflammatory markers (i.e., pentraxin 3 [PTX3], high-sensitivity C-reactive protein [hs-CRP], and interleukin 18) were measured. The data were analyzed using an independent t-test, a chi-square test, and the analysis of covariance.

Results

After adjusting for confounding factors, in the entire study population and in the patients with or without obesity, the patients with the CC genotype showed higher hs-CRP (P=0.001, P=0.008, and P=0.01, respectively) and lower PTX3 (P=0.01, P=0.03, and P=0.04, respectively) in comparison with the T allele carriers. In the patients with the CC genotype, no significant differences were observed in the inflammatory markers between the obese or non-obese patients. However, regarding the T allele carriers, the plasma hs-CRP level was significantly higher in the obese patients compared to the non-obese patients (P=0.01).

Conclusion

In the T2DM patients, the CC genotype could be considered as a risk factor and the T allele as a protective agent against inflammation, which the latter effect might be impaired by obesity. Our results confirmed the anti-atherogenic effect of APO A2, though more studies are required to establish this effect.

Citations

Citations to this article as recorded by  
  • Proteomic Profiling of Extracellular Vesicles Isolated from Plasma and Peritoneal Exudate in Mice Induced by Crotalus scutulatus scutulatus Crude Venom and Its Purified Cysteine-Rich Secretory Protein (Css-CRiSP)
    Armando Reyes, Joseph D. Hatcher, Emelyn Salazar, Jacob Galan, Anton Iliuk, Elda E. Sanchez, Montamas Suntravat
    Toxins.2023; 15(7): 434.     CrossRef
  • ApoA2–256T > C polymorphism interacts with Healthy Eating Index, Dietary Quality Index-International and Dietary Phytochemical Index to affect biochemical markers among type 2 diabetic patients
    Zahra Esmaeily, Gity Sotoudeh, Masoumeh Rafiee, Fariba Koohdani
    British Journal of Nutrition.2022; 127(9): 1343.     CrossRef
  • Interaction between Apo A-II –265T > C polymorphism and dietary total antioxidant capacity on some oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus
    Banafsheh Jafari Azad, Mehdi Yaseri, Elnaz Daneshzad, Fariba Koohdani
    British Journal of Nutrition.2022; 128(1): 13.     CrossRef
  • Deletion allele of Apo B gene is associated with higher inflammation, oxidative stress and dyslipidemia in obese type 2 diabetic patients: an analytical cross-sectional study
    Nasim Mokhtary, Seyedeh Neda Mousavi, Gity Sotoudeh, Mostafa Qorbani, Maryam Dehghani, Fariba Koohdani
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Interaction between Apo A-II -265T>C polymorphism and dietary total antioxidant capacity on some anthropometric indices and serum lipid profile in patients with type 2 diabetes mellitus
    Banafsheh Jafari Azad, Mehdi Yaseri, Elnaz Daneshzad, Fariba Koohdani
    Journal of Nutritional Science.2021;[Epub]     CrossRef
  • A personalised diet study: The interaction between ApoA2 −265T > C polymorphism and dietary inflammatory index on oxidative and inflammatory markers and lipid profile in patients with type 2 diabetes mellitus: A cross‐sectional study
    Elmira Karimi, Pourya Tondkar, Gity Sotoudeh, Mostafa Qorbani, Masoumeh Rafiee, Fariba Koohdani
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Interaction between the dietary indices and PPAR‐γ Pro12Ala gene variants on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Faezeh Abaj, Gity Sotoudeh, Elmira Karimi, Masoumeh Rafiee, Fariba Koohdani
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • A Genetic Score of Predisposition to Low-Grade Inflammation Associated with Obesity May Contribute to Discern Population at Risk for Metabolic Syndrome
    Sebastià Galmés, Margalida Cifre, Andreu Palou, Paula Oliver, Francisca Serra
    Nutrients.2019; 11(2): 298.     CrossRef
  • Study of the relationship between APOA-II −265T>C polymorphism and HDL function in response to weight loss in overweight and obese type 2 diabetic patients
    Masoumeh Moradi, Maryam Mahmoudi, Ahmad Saedisomeolia, Mohammad Ali Mansournia, Roxana Zahirihashemi, Fariba Koohdani
    Clinical Nutrition.2018; 37(3): 965.     CrossRef
  • Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure
    Mu Yang, Yingye Liu, Jian Dai, Lin Li, Xin Ding, Zhe Xu, Masayuki Mori, Hiroki Miyahara, Jinko Sawashita, Keiichi Higuchi
    Scientific Reports.2018;[Epub]     CrossRef
  • Prenatal Exposure to Lipopolysaccharide Induces PTX3 Expression and Results in Obesity in Mouse Offspring
    Shugang Qin, Xin Chen, Meng Gao, Jianzhi Zhou, Xiaohui Li
    Inflammation.2017; 40(6): 1847.     CrossRef
Others
Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
Jong Ho Kim, Sang Soo Kim, Hong Sun Baek, In Kyu Lee, Dong Jin Chung, Ho Sang Sohn, Hak Yeon Bae, Mi Kyung Kim, Jeong Hyun Park, Young Sik Choi, Young Il Kim, Jong Ryeal Hahm, Chang Won Lee, Sung Rae Jo, Mi Kyung Park, Kwang Jae Lee, In Joo Kim
Diabetes Metab J. 2016;40(3):230-239.   Published online April 5, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.230
  • 5,941 View
  • 54 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

We compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add-on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels in Korean patients with type 2 diabetes.

Methods

The present study was a multicenter, randomized, active-controlled investigation comparing the effects of vildagliptin and pioglitazone in Korean patients receiving a stable dose of metformin but exhibiting inadequate glycemic control. Each patient underwent a 16-week treatment period with either vildagliptin or pioglitazone as an add-on treatment to metformin.

Results

The mean changes in HbA1c levels from baseline were –0.94% in the vildagliptin group and –0.6% in the pioglitazone group and the difference between the treatments was below the non-inferiority margin of 0.3%. The mean changes in postprandial plasma glucose (PPG) levels were –60.2 mg/dL in the vildagliptin group and –38.2 mg/dL in the pioglitazone group and these values significantly differed (P=0.040). There were significant decreases in the levels of total, low density lipoprotein, high density lipoprotein (HDL), and non-HDL cholesterol in the vildagliptin group but increases in the pioglitazone group. The mean change in body weight was –0.07 kg in the vildagliptin group and 0.69 kg in the pioglitazone group, which were also significantly different (P=0.002).

Conclusion

As an add-on to metformin, the efficacy of vildagliptin for the improvement of glycemic control is not inferior to that of pioglitazone in Korean patients with type 2 diabetes. In addition, add-on treatment with vildagliptin had beneficial effects on PPG levels, lipid profiles, and body weight compared to pioglitazone.

Citations

Citations to this article as recorded by  
  • Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: A scoping review
    Swetha R. Reghunath, Muhammed Rashid, Viji Pulikkel Chandran, Girish Thunga, K.N. Shivashankar, Leelavathi D. Acharya
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(7): 102790.     CrossRef
  • Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial
    Eugene Han, Ji Hye Huh, Eun Y. Lee, Ji C. Bae, Sung W. Chun, Sung H. Yu, Soo H. Kwak, Kyong S. Park, Byung‐Wan Lee
    Diabetes, Obesity and Metabolism.2022; 24(4): 752.     CrossRef
  • A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
    Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
    Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef
  • The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort
    Gilberto Vargas-Alarcón, María del Carmen González-Salazar, Christian Vázquez-Vázquez, Adrián Hernández-Díaz Couder, Fausto Sánchez-Muñoz, Juan Reyes-Barrera, Sergio A. Criales-Vera, Marco Sánchez-Guerra, Citlalli Osorio-Yáñez, Rosalinda Posadas-Sánchez
    Frontiers in Genetics.2021;[Epub]     CrossRef
  • Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials
    A.J. Scheen
    Diabetes & Metabolism.2020; 46(3): 186.     CrossRef
  • Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
    Min Kyong Moon
    The Journal of Korean Diabetes.2018; 19(1): 23.     CrossRef
  • Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea
    Kyoung Hwa Ha, Bongseong Kim, Hae Sol Shin, Jinhee Lee, Hansol Choi, Hyeon Chang Kim, Dae Jung Kim
    Korean Circulation Journal.2018; 48(5): 395.     CrossRef
  • Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
    Bancha Satirapoj, Khanin Watanakijthavonkul, Ouppatham Supasyndh, Stephen L Atkin
    PLOS ONE.2018; 13(10): e0206722.     CrossRef
  • Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
    Min Kyong Moon, Kyu Yeon Hur, Seung-Hyun Ko, Seok-O Park, Byung-Wan Lee, Jin Hwa Kim, Sang Youl Rhee, Hyun Jin Kim, Kyung Mook Choi, Nan-Hee Kim
    The Korean Journal of Internal Medicine.2017; 32(6): 974.     CrossRef
  • Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
    Min Kyong Moon, Kyu-Yeon Hur, Seung-Hyun Ko, Seok-O Park, Byung-Wan Lee, Jin Hwa Kim, Sang Youl Rhee, Hyun Jin Kim, Kyung Mook Choi, Nan-Hee Kim
    Diabetes & Metabolism Journal.2017; 41(5): 357.     CrossRef
  • Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
    Sang‐Mo Hong, Cheol‐Young Park, Dong‐Min Hwang, Kyung Ah Han, Chang Beom Lee, Choon Hee Chung, Kun‐Ho Yoon, Ji‐Oh Mok, Kyong Soo Park, Sung‐Woo Park
    Diabetes, Obesity and Metabolism.2017; 19(5): 654.     CrossRef
  • Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
    Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
    The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
  • Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
    Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
    Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
Others
Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
Sejeong Park, So Young Park, Yu Jin Kim, Soo Min Hong, Suk Chon, Seungjoon Oh, Jeong-taek Woo, Sung-Woon Kim, Young Seol Kim, Sang Youl Rhee
Diabetes Metab J. 2016;40(3):240-247.   Published online April 5, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.240
  • 6,167 View
  • 69 Download
  • 5 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide treatment in patients with T2DM.

Methods

Patients with T2DM and atypical GI symptoms were enrolled. They took rebamipide (100 mg thrice daily) for 12 weeks and filled out the diabetes bowel symptom questionnaire (DBSQ) before and after rebamipide treatment. The DBSQ consisted of 10 questions assessing the severity of GI symptoms by a 1 to 6 scoring system. Changes in the DBSQ scores before and after rebamipide treatment were analyzed to evaluate any improvements of GI symptoms.

Results

A total of 107 patients were enrolled, and 84 patients completed the study. The mean age was 65.0±7.8, 26 patients were male (24.8%), the mean duration of T2DM was 14.71±9.12 years, and the mean glycosylated hemoglobin level was 6.97%±0.82%. The total DBSQ score was reduced significantly from 24.9±8.0 to 20.4±7.3 before and after rebamipide treatment (P<0.001). The DBSQ scores associated with reflux symptoms, indigestion, nausea or vomiting, abdominal bloating or distension, peptic ulcer, abdominal pain, and constipation were improved after rebamipide treatment (P<0.05). However, there were no significant changes in symptoms associated with irritable bowel syndrome, diarrhea, and anal incontinence. No severe adverse events were reported throughout the study.

Conclusion

Rebamipide treatment for 12 weeks improved atypical GI symptoms in patients with T2DM.

Citations

Citations to this article as recorded by  
  • INFLUENCE OF TYPE 2 DIABETES ON THE EFFICIENCY OF ENDOSCOPIC HEMOSTASIS FOR BLEEDING FROM PEPTIC GASTRODUODENAL ULCER
    V. O. Shaprynskyi, M. V. Hmoshynskyi, V. R. Taheiev
    Kharkiv Surgical School.2024; (2-3): 36.     CrossRef
  • Effectiveness of Rebamipide as a part of the Helicobacter pylori eradication therapy in Russia: a meta-analysis of controlled trials
    Dmitry N. Andreev, Igor V. Maev, Dmitry S. Bordin, Svetlana V. Lyamina, Diana T. Dicheva, Aleksei K. Fomenko, Armine S. Bagdasarian
    Consilium Medicum.2022; 24(5): 333.     CrossRef
  • Сompliance in patients with coronary heart disease and erosive-ulcerative gastroduodenopathy
    A. R. Molchanova, A. I. Dolgushina, A. A. Seljanina
    Experimental and Clinical Gastroenterology.2020; (6): 82.     CrossRef
  • Rebamipide: evidence base for use in gastroenterology
    D. N. Andreev, I. V. Maev
    Terapevticheskii arkhiv.2020; 92(12): 97.     CrossRef
  • Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis
    Mohamed Hasif Jaafar, Sher Zaman Safi, Maw-Pin Tan, Sanjay Rampal, Sanjiv Mahadeva
    Digestive Diseases and Sciences.2018; 63(5): 1250.     CrossRef
  • Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2016;40:240-7)
    Jin Hwa Kim
    Diabetes & Metabolism Journal.2016; 40(4): 334.     CrossRef
  • Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)
    Sejeong Park, So Young Park, Sang Youl Rhee
    Diabetes & Metabolism Journal.2016; 40(4): 336.     CrossRef
Letter
Response
Response: Hyperglycemia Is Associated with Impaired Muscle Quality in Older Men with Diabetes: The Korean Longitudinal Study on Health and Aging (Diabetes Metab J 2016;40:140-6)
Ji Won Yoon, Hak Chul Jang
Diabetes Metab J. 2016;40(3):250-251.   Published online June 20, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.3.250
  • 3,662 View
  • 32 Download
  • 5 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Risk Factors of Sarcopenia in COPD Patients: A Meta-Analysis
    Jingru Zhou, Yanjun Liu, Fang Yang, Meiling Jing, Xiaoli Zhong, Yanfen Wang, Yan Liu, Wenwen Ming, Huangyan Li, Tianxia Zhao, Lin He
    International Journal of Chronic Obstructive Pulmonary Disease.2024; Volume 19: 1613.     CrossRef
  • Muscle Quality in Older Adults: A Scoping Review
    Charles Phillipe de Lucena Alves, Samuel Brito de Almeida, Danielle Pessoa Lima, Pedro Braga Neto, Ana Lúcia Miranda, Todd Manini, Lara Vlietstra, Debra L. Waters, Renata Moraes Bielemann, Rosaly Correa-de-Araujo, Ana Paula Fayh, Eduardo Caldas Costa
    Journal of the American Medical Directors Association.2023; 24(4): 462.     CrossRef
  • Neuromuscular dysfunction and exercise training in people with diabetic peripheral neuropathy: A narrative review
    Giorgio Orlando, Stefano Balducci, Andrew J.M. Boulton, Hans Degens, Neil D. Reeves
    Diabetes Research and Clinical Practice.2022; 183: 109183.     CrossRef
  • DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients
    Canberk Sencan, Fatma Sena Dost, Esra Ates Bulut, Ahmet Turan Isik
    Experimental Gerontology.2022; 164: 111832.     CrossRef
  • Níveis glicêmicos e sarcopenia em idosos com diabetes mellitus do tipo 2
    Isabella Stoeterau, Deise Regina Baptista, Andrea Pires Muller, Juliana Ceronato, Magda Rosa Ramos da Cruz, Carla Viana Dendasck
    Revista Científica Multidisciplinar Núcleo do Conhecimento.2022; : 53.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP